What can we make bigger?

Explore how JFK helps life science companies turn complex science, pivotal moments, and ambitious ideas into stories that matter.

MOMENTS

NEWS

MOVES

DATA

RELATIONSHIPS

VOICES

Capabilities

What can we make bigger?

Moments

Big Moments

Congresses & Events

Planning the fixed points of the life science year — congresses, symposia and data presentations — far enough ahead that they can be shaped rather than covered.

News

BIG NEWS

Media Relations

Earned media that reaches the audiences who matter — trade, business and scientific press — built on relationships and a working knowledge of the science.

Data

BIG DATA

Clinical Communications

Turning clinical and scientific data into a narrative that holds up — for publications, regulatory milestones and investor moments — without losing the science.

Moves

BIG MOVES

Corporate & Product Communications

Communications around launches, approvals, label changes and corporate milestones — from planning through execution.

Relationships

BIG RELATIONSHIPS

KOL & Advocacy

Building durable relationships with key opinion leaders, patient organizations and advocacy groups, grounded in what those communities actually need.

Voices

BIG VOICES

Executive Thought Leadership

Positioning executives and scientific leaders as credible voices — and preparing them to hold that position under questioning.

AI-augmented insight

Human judgment. AI intelligence. Better decisions.

AI expands what we can see. Experience determines what we do with it.

JFK combines deep life-science communications expertise with the speed and analytical power of today's leading AI platforms. We're platform-agnostic, selecting the right technologies to analyze information, uncover patterns, accelerate research and explore possibilities.

But technology doesn't make the final call. Experienced people do. Human judgment provides the context, nuance, scientific understanding and strategic perspective that turn AI processing into sound communications decisions.

How We Work

AI processing

Speed

Scale

Pattern recognition

Multiple perspectives

Deeper analysis

Human wisdom

Experience

Judgment

Context

Relationships

Strategic thinking

Clearer insight. Stronger decisions.

Oncology isn’t a category. It’s a specialty.

JFK understands oncology from the inside — the science, the stakeholders, the regulatory environment, and the pivotal moments that shape a treatment's development and commercialization. From emerging biotechs to established pharmaceutical companies, we help innovators communicate complex science and advance important conversations with clinicians, patients, media, and other stakeholders.

Inside big pharma
Oncology from the inside. Before JFK, John Kouten held communications roles inside Sanofi, Bristol Myers Squibb, and Johnson & Johnson, including leadership of global oncology communications. That experience included launching and supporting scores of cancer medicines and navigating the scientific, regulatory, commercial, and reputational complexities that surround them.
Oncology specialty
More than 20 years across the oncology continuum. Since founding JFK, our teams have led oncology communications for organizations ranging from global pharmaceutical companies to emerging biotechs and diagnostics innovators—including Novartis Oncology, Taiho Oncology, Eisai, AVEO Oncology, Prometheus Laboratories, and Caris Life Sciences. The work spans company sizes, technologies, tumor types, and stages of development.
ASCO & Medical meetings
Decades at the center of oncology’s biggest meetings. JFK teams have worked more than 25 ASCO Annual Meetings, building longstanding relationships with congress press teams, oncology journalists, and communications offices at leading cancer centers. We know how to maximize a main-stage Phase 3 presentation—and how to work harder to make a promising Phase 2 poster command attention.
Clinical data fluency
Science that holds up. Complex trials. Nuanced endpoints. Data that require careful interpretation. JFK helps translate clinical results into credible communications that build awareness without getting ahead of the science—or jeopardizing downstream publication. The result: messages designed to hold up with clinicians, media, investors, patients, and other critical stakeholders.
Questions

A few BIG questions you may have.

What makes JFK different from a larger life science agency?
Arrow down
Who will actually work on our business?
Arrow down
When should we bring JFK into the conversation?
Arrow down
Can JFK plug into our existing team?
Arrow down
How flexible is the way we can work together?
Arrow down
What kinds of moments does JFK typically help clients navigate?
Arrow down
How does JFK use AI without losing human judgment?
Arrow down
Got something BIG to share?

A breakthrough. A milestone. A challenge. An idea that deserves more attention. Tell us what’s next.

Ask a BIG Question